Looking to publish in Liver Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowLiver Cancer publishes clinical and translational research on the causes, mechanisms, prevention, surveillance, diagnosis, and treatment of liver malignancy in humans and experimental models, including molecular targeted therapy, in the form of original and review articles.
Looking to publish in Liver Cancer? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Liver Cancer accepts the following article types. Click on an article type to view submission instructions.
Research Article
Review Article
Systematic Review
Brief Report
Case Report
Guidelines
Letter
Registered Report-Stage 1
Registered Report-Stage 2
Recent Publications
Exposure to poly- and perfluoroalkyl substances and risk of hepatocellular carcinoma in male patients with cirrhosis related to HCV infection
Aaron P. Thrift, Noura Abdulrahman, Priya B. Shetty, Hyeyeun Lim, Yanyan Chen, Hashem B. El-Serag
Selective Conventional Transarterial Chemoembolization Using a Glass Membrane Emulsification Device in Hepatocellular Carcinoma: Multicenter Clinical Trial in Japan
Toshihiro Tanaka, Hiroshi Anai, Tetsuya Masada, Satoru Sueyoshi, Takeshi Sato, Shohei Toyoda, Takeshi Matsumoto, Yuto Chanoki, Keisuke Oshima, Sho Shimizu, Mariko Irizato, Ryosuke Taiji, Kiyoyuki Minamiguchi, Hideki Kunichika, Hiroyuki Kurakami, Shigeo Ichihashi, Hideyuki Nishiofuku
Lenvatinib Versus Sorafenib in First-Line Treatment of Older Patients With Unresectable Hepatocellular Carcinoma: A Subgroup Analysis of the REFLECT Trial
Masatoshi Kudo, Arndt Vogel, Thomas R. Jeffry Evans, Yuk Ting Ma, Bruno Daniele, Ari David Baron, Amit Mahipal, Shukui Qin, Jean Frederic Blanc, Carlos Lopez Lopez, Ann-Lii Cheng, Su Pin Choo, Fabio Piscaglia, Kalgi Mody, Min Ren, Stephen Lam Chan
Alcohol plays a detrimental role in the prognosis of hepatocellular carcinoma related to steatotic liver disease
Stefano Gitto, Alessandro Vitale, Gianluca Svegliati-Baroni, Giulio Marchesini, Francesco Paolo Russo, Luca Miele, Claudia Campani, Valentina Adotti, Martina Rosi, Francesco Vizzutti, Mariarosaria Marseglia, Andrea Martini, Angelo Sangiovanni, Giuseppe Cabibbo, Giacomo Zaccherini, Giorgia Ghittoni, Maria Di Marco, Francesco Giuseppe Foschi, Filomena Morisco, Sara Grasselli, Carlo Saitta, Francesca Romana Ponziani, Maurizia Rossana Brunetto, Donatella Magalotti, Francesco Azzaroli, Andrea Mega, Rodolfo Sacco, Gerardo Nardone, David Sacerdoti, Sara Boninsegna, Gianpaolo Vidili, Franco Trevisani, Edoardo G. Giannini, Fabio Marra
An updated systematic review and meta-analysis of modern radiotherapy techniques for hepatocellular carcinoma
Sun Hyun Bae, Won Il Jang, Jeong Il Yu, Ji Eun Moon, Hee Chul Park, Mi Sook Kim
Frequently asked questions
How long does it take to publish?
Accepted papers are published online in the unedited original manuscript version within a few days of acceptance. Authors should respond to proof queries within 48 hours. Articles are published electronically ahead of print shortly after author approval to publish.
Reformat to Liver Cancer using Livewrite PremiumIs a cover letter required?
A cover letter is required and should describe the gap in knowledge addressed by the manuscript, the implications and significance of the research, how the manuscript fits the journal scope, and the manuscript’s unique and important contributions. Submissions for a special issue or article collection should name the collection and identify who invited the submission where appropriate.
Reformat to Liver Cancer using Livewrite PremiumWhat are the publication costs?
Article Processing Charges (APCs) apply for Gold Open Access and Open Access options in hybrid journals; waivers and discounts are available for authors without means.
Reformat to Liver Cancer using Livewrite Premium